Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants - a Randomized, Double-blind, Placebo-controlled, Prospective, and Multicenter Clinical Study

NCT02076373 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.

NCT NCT02076373
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02076373 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants - a Randomized, Double-blind, Placebo-controlled, Prospective, and Multicenter Clinical Study
Lead sponsor
University of Zurich
Phase
Phase 3
Overall status
Unknown status
Start date
March 31, 2014
Completion date
March 31, 2024
Enrollment
120 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

intraventricular hemorrhage of prematurity